Use of antisense oligonucleotides or small interfering RNAs that target TMPRSS6 has been shown to improve anaemia and iron overload in mice and other preclinical models of β-thalassaemia [49,50,51]. Here, TMPRSS6 is linked to anemia (phenotype).